跳至主要内容
临床试验/IRCT20231220060477N1
IRCT20231220060477N1招募中3 期

Investigating and comparing the effect of ketorolac 30 mg intravenous and haloperidol 5 mg intravenous in reducing the intensity of primary headache in patients with the chief complaint of headache at the emergency department of Sina Hospital.

Tehran University of Medical Sciences0 个研究点目标入组 12 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • patients aged 18 to 55 who have visited the emergency room with the main complaint of headache.

排除标准

  • Abnormal blood pressure(>200/100 mmhg)
  • thunderclap (normal to the worst pain due to short time)
  • acute trauma
  • history of brain mass
  • history of stroke
  • history of anatomic malformation of brain
  • Qtc>450 ms in EKG
  • altered mental status (GCS<15)
  • Haloperidol allergy
  • Ketorolac allergy
  • airway disease such as asthema
  • active peptic ulcer
  • advanced renal failure
  • recent major sergury
  • any suspicious which lead to use of CT scan or LP
  • QT interval prolong drugs
  • hepatic failure
  • epilepsy or history of seizure
  • hyperthyroidism
  • parkinsonism
  • chronic psychiatrics disease
  • Concomitant use or within 2 weeks of discontinuing an MAOI inhibitor
  • active gastritis
  • history of GI bleeding
  • Previous participation in the same study
  • Previous enrollment in a study that may interfere with the current study
  • Lack of consent to participate in the study
  • Unwillingness to sign the consent form

研究者

相似试验